Canagliflozin is available in tablet form, and it is taken orally, typically once a day. Here’s how to use it correctly:
- Administration: Take canagliflozin once daily in the morning, with or without food. It’s essential to take it at the same time each day for better adherence to the treatment schedule.
- Missed Dose: If a dose is missed, take it as soon as you remember, unless it is almost time for the next dose. In that case, skip the missed dose and resume your usual dosing schedule. Never take two doses at once to make up for a missed dose.
- Hydration: It is important to stay well-hydrated while using canagliflozin, as the drug increases urination and can lead to dehydration.
- Monitoring: Regular blood sugar monitoring is necessary to assess the effectiveness of the drug. Kidney function should also be monitored periodically, especially in patients with pre-existing kidney conditions or other risk factors for kidney disease.
Canagliflozin is an oral medication that inhibits the sodium-glucose co-transporter 2 (SGLT2) protein in the kidneys. This protein plays a significant role in glucose reabsorption, meaning that under normal conditions, the kidneys filter glucose and then reabsorb most of it into the bloodstream. By blocking the SGLT2 protein, canagliflozin reduces glucose reabsorption, allowing excess glucose to be excreted in the urine, which helps lower blood sugar levels.
- SGLT2 inhibition: SGLT2 is a protein in the kidneys that is responsible for reabsorbing glucose from the urine back into the bloodstream. By inhibiting this transporter, canagliflozin causes excess glucose to be excreted in the urine, reducing the amount of glucose in the bloodstream.
Diuretic effect: Canagliflozin also has a mild diuretic effect, which can help reduce blood pressure by causing fluid loss through increased urination. This is beneficial for individuals with type 2 diabetes who may also have high blood pressure or heart disease.
Like all medications, canagliflozin can cause side effects. Some are common and mild, while others may be more serious. Common side effects include:
- Genital infections: Because the drug increases glucose in the urine, it can lead to a higher risk of urinary tract infections (UTIs) and genital fungal infections, particularly in women.
- Dehydration: Due to its diuretic effect, canagliflozin may cause dehydration, leading to symptoms like dizziness, lightheadedness, and fainting.
- Low blood pressure (hypotension): Canagliflozin may lower blood pressure, particularly when starting treatment or when combined with other blood pressure-lowering medications.
- Electrolyte imbalances: The drug may cause an imbalance in important electrolytes such as sodium, potassium, and magnesium, which may result in symptoms like fatigue, muscle cramps, and irregular heartbeats.
- Kidney problems: Canagliflozin can increase the risk of kidney-related issues, especially in patients with pre-existing kidney conditions or dehydration. Kidney function should be monitored regularly.
- Ketoacidosis: Although rare, canagliflozin can cause diabetic ketoacidosis (DKA), a serious condition in which the body produces high levels of ketones. This is more likely in patients with type 1 diabetes but can also occur in those with type 2 diabetes, particularly in times of illness or dehydration.
- Bone fractures: Some studies suggest that canagliflozin may increase the risk of bone fractures, particularly in the lower extremities.
Canagliflozin should be used with caution in certain groups of people and under specific conditions:
- Kidney disease: Canagliflozin is contraindicated in patients with severe kidney impairment (eGFR less than 30 mL/min/1.73 m²) or in patients on dialysis.
- Dehydration: Individuals who are dehydrated, such as those with vomiting, diarrhea, or excessive sweating, should avoid using canagliflozin or should use it under close medical supervision.
- Hypotension: Patients with low blood pressure or those taking medications that lower blood pressure should use canagliflozin cautiously.
- Diabetic ketoacidosis (DKA): Although rare, canagliflozin can increase the risk of DKA, and patients should be monitored for symptoms of this condition.
- Pregnancy and breastfeeding: Canagliflozin should not be used during pregnancy or breastfeeding unless the potential benefit outweighs the risks. Consult with a healthcare provider to assess the risks.
The recommended starting dose for canagliflozin for the treatment of type 2 diabetes is 100 mg once daily. If tolerated, the dose can be increased to 300 mg daily for better blood sugar control. For patients with kidney problems or those at risk of dehydration, the initial dose may remain at 100 mg.
- Type 2 diabetes management: Start with 100 mg daily, and increase to 300 mg if necessary.
- Cardiovascular risk reduction: The starting dose is typically 100 mg once daily, with an increase to 300 mg if needed.
- Kidney function: The dose of canagliflozin should be adjusted based on the patient’s kidney function (eGFR). The medication is not recommended for patients with severe kidney impairment.
Canagliflozin is a prescription medication, which means it must be prescribed by a healthcare provider. A healthcare provider will assess the patient’s overall health, including kidney function, blood pressure, and the presence of other conditions like heart disease, before prescribing canagliflozin. Regular monitoring of kidney function, blood sugar levels, and other health parameters is necessary to ensure the medication is working effectively and safely.